Khurram Jamil's most recent trade in Galectin Therapeutics Inc was a trade of 65,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 23, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Galectin Therapeutics Inc | Khurram Jamil | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2025 | 65,000 | 65,000 | - | - | Stock Option (right to buy) | |
| Galectin Therapeutics Inc | Khurram Jamil | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2025 | 60,000 | 60,000 | - | - | Restricted Stock Unit | |
| Galectin Therapeutics Inc | Jamil Khurram | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2024 | 40,000 | 40,000 (0%) | 0% | 0 | Common Stock | |
| Galectin Therapeutics Inc | Khurram Jamil | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2024 | 40,000 | 0 | - | - | Restricted Stock Units | |
| Galectin Therapeutics Inc | Jamil Khurram | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 0.88 per share. | 23 Dec 2024 | 13,654 | 26,346 (0%) | 0% | 0.9 | 12,044 | Common Stock |
| Galectin Therapeutics Inc | Khurram Jamil | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2024 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Galectin Therapeutics Inc | Khurram Jamil | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2024 | 10,000 | 10,000 | - | - | Restricted Stock Unit |